MABs in Gastric Cancer - biomarkers, benefit and nursing through the first cycles

GI cancer nurses Alana Fitzgibbon (Hobart) and Catherine Trevaskis (Canberra) discuss the shift toward biomarker-driven care in gastric and gastro-oesophageal junction cancer, centred on the newly available targeted therapies — so nurses can help patients stay on treatment and receive the full benefit of this new personalised medicine. This is a member-only episode. Access the full podcast by entering your log in details at https://www.cnsa.org.au/